Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Dau

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Journal of Clinical Apheresis|January 1, 1988
Reduction of low-density lipoproteins with dextran sulfate in patients with familial hypercholesterolemiaG D Antwiler, P C Dau, D D Lobdell
Muscle & Nerve|May 1, 1981
Antibody-negative acquired myasthenia gravis: successful therapy with plasma exchangeR G Miller, H S Milner-Brown, P C Dau
Lancet (London, England)|December 1, 1979
Recovery from chronic progressive polyneuropathy after treatment with plasma exchange and cyclophosphamideH Fowler, M Vulpe, G Marks, et al.
JAMA|November 21, 1980
Immunologic mechanisms in multiple sclerosis. Exacerbation by type A hepatitis and skin test antigensR L Owen, P C Dau, K P Johnson, et al.
Anesthesia and Analgesia|May 1, 1986
Heparin-associated thrombocytopenia: alternative managementsJ S Vender, E B Matthew, I M Silverman, et al.
Neurology|October 1, 1980
Plasmapheresis in multiple sclerosis: preliminary findingsP C Dau, J H Petajan, K P Johnson, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1983
Clinical plasmapheresis - who needs it?H J Gurland, P C Dau, M J Lysaght, et al.
The New England Journal of Medicine|November 24, 1977
Plasmapheresis and immunosuppressive drug therapy in myasthenia gravisP C Dau, J M Lindstrom, C K Cassel, et al.
Clinical and Experimental Immunology|March 1, 1979
Progressive rubella panencephalitis: immunovirological studies and results of isoprinosine therapyJ S Wolinsky, P C Dau, E Buimovici-Klein, et al.
Journal of Clinical Apheresis|January 1, 1986
Clinical applications of therapeutic apheresis. Report of the Clinical Applications Committee, American Society for ApheresisH G Klein, J E Balow, P C Dau, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of Clinical Apheresis|January 1, 1988
Reduction of low-density lipoproteins with dextran sulfate in patients with familial hypercholesterolemiaG D Antwiler, P C Dau, D D Lobdell
Muscle & Nerve|May 1, 1981
Antibody-negative acquired myasthenia gravis: successful therapy with plasma exchangeR G Miller, H S Milner-Brown, P C Dau
Lancet (London, England)|December 1, 1979
Recovery from chronic progressive polyneuropathy after treatment with plasma exchange and cyclophosphamideH Fowler, M Vulpe, G Marks, et al.
JAMA|November 21, 1980
Immunologic mechanisms in multiple sclerosis. Exacerbation by type A hepatitis and skin test antigensR L Owen, P C Dau, K P Johnson, et al.
Anesthesia and Analgesia|May 1, 1986
Heparin-associated thrombocytopenia: alternative managementsJ S Vender, E B Matthew, I M Silverman, et al.
Neurology|October 1, 1980
Plasmapheresis in multiple sclerosis: preliminary findingsP C Dau, J H Petajan, K P Johnson, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1983
Clinical plasmapheresis - who needs it?H J Gurland, P C Dau, M J Lysaght, et al.
The New England Journal of Medicine|November 24, 1977
Plasmapheresis and immunosuppressive drug therapy in myasthenia gravisP C Dau, J M Lindstrom, C K Cassel, et al.
Clinical and Experimental Immunology|March 1, 1979
Progressive rubella panencephalitis: immunovirological studies and results of isoprinosine therapyJ S Wolinsky, P C Dau, E Buimovici-Klein, et al.
Journal of Clinical Apheresis|January 1, 1986
Clinical applications of therapeutic apheresis. Report of the Clinical Applications Committee, American Society for ApheresisH G Klein, J E Balow, P C Dau, et al.
Pageof 6